Risk Factors for Central and Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study.

Objective To analyze the risk factors for central cervical lymph node metastasis (CLNM) in clinically node-negative (cN0) papillary thyroid microcarcinoma (PTMC) patients, thereby informing decisions regarding the extent of surgical dissection and the selection of candidates for active surveillance (AS). Additionally, to evaluate the incidence and determinants of lateral cervical lymph node metastasis (LLNM) in clinically node-positive (cN1) PTMC patients, facilitating postoperative risk stratification and follow-up management. Methods This study enrolled 519 patients who underwent surgery for pathologically confirmed PTMC at Beijing Sixth Hospital between 2023 and 2025. Clinicopathological data, including age, sex, maximal tumor diameter, tumor laterality, tumor location, number of foci, capsule invasion, extrathyroidal extension, coexistence of Hashimoto's thyroiditis (HT), and cervical lymph node status, were retrospectively collected. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for CLNM and LLNM. Results Among the 519 patients, cervical lymph node metastasis was observed in 232 cases (44.70%), while 287 (55.30%) had no nodal involvement. Specifically, isolated CLNM occurred in 201 patients (38.73%), concurrent CLNM and LLNM in 28 (5.39%), and skip lateral metastasis (without central compartment involvement) in 3 (0.58%). Male sex (p = 0.045), age <45 years (p < 0.001), and maximal tumor diameter ≥0.5 cm (p < 0.001) were identified as independent risk factors for CLNM. For LLNM, independent predictors included maximal tumor diameter ≥0.5 cm (p = 0.014) and the presence of concomitant CLNM (p = 0.001). Conclusion Male sex, age <45 years, and tumor size ≥0.5 cm are independent risk factors for CLNM in PTMC. For patients with these characteristics, proactive surgical intervention with prophylactic central lymph node dissection (CLND) is warranted. Conversely,patients without these risk factors could potentially be spared from prophylactic CLND or even surgery, and may be suitable for AS. Additionally, tumor diameter ≥0.5 cm and coexisting CLNM are independent predictors of LLNM; patients with these features should be categorized as high-risk for recurrence and receive intensified postoperative surveillance.

Authors

Publication Details

Journal
PubMed
Published
2026-11-13
DOI
https://doi.org/10.1159/ocl/aebag028
Primary Topic
Thyroid Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Risk Factors for Central and Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study.

Xuemei Wu
1 links
PubMed
Thyroid Cancer Diagnosis and Treatment
article

Risk Factors for Central and Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study.

Xuemei Wu
article en

Abstract

Objective To analyze the risk factors for central cervical lymph node metastasis (CLNM) in clinically node-negative (cN0) papillary thyroid microcarcinoma (PTMC) patients, thereby informing decisions regarding the extent of surgical dissection and the selection of candidates for active surveillance (AS). Additionally, to evaluate the incidence and determinants of lateral cervical lymph node metastasis (LLNM) in clinically node-positive (cN1) PTMC patients, facilitating postoperative risk stratification and follow-up management. Methods This study enrolled 519 patients who underwent surgery for pathologically confirmed PTMC at Beijing Sixth Hospital between 2023 and 2025. Clinicopathological data, including age, sex, maximal tumor diameter, tumor laterality, tumor location, number of foci, capsule invasion, extrathyroidal extension, coexistence of Hashimoto's thyroiditis (HT), and cervical lymph node status, were retrospectively collected. Univariate and multivariate logistic regression analyses were performed to identify independent risk factors for CLNM and LLNM. Results Among the 519 patients, cervical lymph node metastasis was observed in 232 cases (44.70%), while 287 (55.30%) had no nodal involvement. Specifically, isolated CLNM occurred in 201 patients (38.73%), concurrent CLNM and LLNM in 28 (5.39%), and skip lateral metastasis (without central compartment involvement) in 3 (0.58%). Male sex (p = 0.045), age <45 years (p < 0.001), and maximal tumor diameter ≥0.5 cm (p < 0.001) were identified as independent risk factors for CLNM. For LLNM, independent predictors included maximal tumor diameter ≥0.5 cm (p = 0.014) and the presence of concomitant CLNM (p = 0.001). Conclusion Male sex, age <45 years, and tumor size ≥0.5 cm are independent risk factors for CLNM in PTMC. For patients with these characteristics, proactive surgical intervention with prophylactic central lymph node dissection (CLND) is warranted. Conversely,patients without these risk factors could potentially be spared from prophylactic CLND or even surgery, and may be suitable for AS. Additionally, tumor diameter ≥0.5 cm and coexisting CLNM are independent predictors of LLNM; patients with these features should be categorized as high-risk for recurrence and receive intensified postoperative surveillance.

PubMed
Good health and well-being
Thyroid Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon